{"organizations": [], "uuid": "4354fdedd38221ee54a66f2e07d0602164b4bd3b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "in.reuters.com", "main_image": "https://s3.reutersmedia.net/resources/r/?d=20180124&i=RCV004EOL&w=1200&r=RCV004EOL&t=2", "site_section": "http://feeds.reuters.com/reuters/VideoINLatest", "section_title": "Reuters Video: Latest Videos IN", "url": "https://in.reuters.com/video/2018/01/24/pharma-firms-need-to-do-more-to-counter?videoId=388309670", "country": "US", "domain_rank": 408, "title": "Pharma firms 'need to do more' to counter superbugs", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-24T07:39:00.000+02:00", "replies_count": 0, "uuid": "4354fdedd38221ee54a66f2e07d0602164b4bd3b"}, "author": "", "url": "https://in.reuters.com/video/2018/01/24/pharma-firms-need-to-do-more-to-counter?videoId=388309670", "ord_in_thread": 0, "title": "Pharma firms 'need to do more' to counter superbugs", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Pharma firms 'need to do more' to counter superbugs Wednesday, January 24, 2018 - 02:01 \nDrugmakers' response to the threat posed by ''superbugs'' remains patchy even after years of warnings, according to the first analysis of individual companies' efforts to tackle the antibiotic resistance crisis.   \nDrugmakers' response to the threat posed by \"superbugs\" remains patchy even after years of warnings, according to the first analysis of individual companies' efforts to tackle the antibiotic resistance crisis.  //reut.rs/2na2E8b", "external_links": [], "published": "2018-01-24T07:39:00.000+02:00", "crawled": "2018-01-24T08:12:44.002+02:00", "highlightTitle": ""}